
A U.S. federal judge ruled on Thursday against compounding pharmacies seeking permission to continue producing copies of Novo Nordisk's widely popular diabetes and weight-loss drugs, Ozempic and Wegovy, while a legal battle over drug shortages continues. Judge Mark Pittman of the U.S. District Court in Texas rejected a request from... Read More »